Skip to main content
. 2022 Jun 17;14:903619. doi: 10.3389/fnagi.2022.903619

FIGURE 3.

FIGURE 3

The concentration of serum IL-15 (A), MCP-1 (B), and TNF-β (C) between low risk and intermediate-high risk patients. *P < 0.05; ***P < 0.01. IL-15, interleukin 15; MCP-1, monocyte chemoattractant protein-1; TNF-β, tumor necrosis factors-β.